Gilead Moves Closer to Filing Novel HIV Combo Afte...
Category : Clinical Trial Update 17 December 2025Gilead Sciences is accelerating toward regulatory submissions for its next-generation HIV treatment...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
TempraMed Secures New South Korea Patent for VIVI...
Category : Product Related Updates 17 December 2025TempraMed Technologies has strengthened its global intellectual property portfolio with a newly gran...
Argenx permanently grounds studies of high-flying...
Category : Clinical Trial Update 16 December 2025"While argenx has been able to demonstrate the merit of its FcRn drug Vyvgart in multiple autoi...
Novo’s oral semaglutide edges out CagriSema, Lilly...
Category : Product Related Updates 16 December 2025"As both Novo Nordisk and Eli Lilly race to develop their long-anticipated oral GLP-1 obesity m...
Scienture and BlinkRx Partner to Expand Access to...
Category : Licensing/Collaboration Deal 13 December 2025Scienture Holdings Inc has announced a strategic collaboration with Blink Rx to expand nationwide ac...
Latest Newsletter Post
-
TempraMed Secures New South Korea P..
17 December 2025
-
Gilead Moves Closer to Filing Novel..
17 December 2025
-
Novo’s oral semaglutide edges out C..
16 December 2025
-
Argenx permanently grounds studies..
16 December 2025
-
Novo Nordisk Launches Ozempic in In..
13 December 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com